Medlab Clinical Limited filed its F-1 on Oct 13, 2022 for the period ending Jun 30, 2022. In this report its auditor, Accell Audit & Compliance, P.A, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 AUD | -.--% | -5.04% | -.--% |
05-15 | Medlab Clinical Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
04-24 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 10.07M | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.69% | 22.27B | |
-12.64% | 22.22B | |
-5.20% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- MDC Stock
- News Medlab Clinical Limited
- Medlab Clinical Limited Auditor Raises 'Going Concern' Doubt